LENZ Therapeutics, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
5.00 |
12.89 |
49.74 |
128.01 |
216.82 |
340.02 |
| Przychód Δ r/r |
0.00% |
157.82% |
285.84% |
157.36% |
69.39% |
56.82% |
| Przychód (min) |
4.08 |
9.39 |
41.17 |
128.01 |
176.71 |
277.12 |
| Przychód (max) |
6.22 |
21.00 |
60.28 |
128.01 |
269.91 |
423.27 |
| EBITDA (średnia) |
3.00 |
7.73 |
29.84 |
76.80 |
130.09 |
204.01 |
| EBIT (średnia) |
3.00 |
7.73 |
29.84 |
76.80 |
130.09 |
204.01 |
| EBIT % |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
60.00% |
| Zysk netto (średni) |
-56.04 |
-55.32 |
-75.85 |
-11.52 |
32.77 |
90.60 |
| Zysk netto % |
-1120.85% |
-429.12% |
-152.49% |
-9.00% |
15.11% |
26.65% |
| EPS (średnia) |
-2.68 |
-2.60 |
-2.54 |
-0.52 |
1.54 |
4.26 |
| Liczba analityków (Przychody) |
8 |
6 |
8 |
6 |
2 |
5 |
| Liczba analityków (EPS) |
4 |
6 |
6 |
4 |
3 |
2 |
| symbol |
LENZ |
LENZ |
LENZ |
LENZ |
LENZ |
LENZ |